Orthopediatrics CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
OrthoPediatrics Corp. has scheduled its 2026 annual meeting of stockholders for June 4, 2026, to address director elections, executive compensation, and an incentive plan amendment.
NASDAQ
DEFR14A: OrthoPediatrics Corp. Amends Proxy Statement for XBRL Tagging in Pay Versus Performance Disclosure
OrthoPediatrics Corp. files an amendment to its proxy statement solely to include required Inline XBRL tagging in the Pay Versus Performance section, with no other changes to the document.
NASDAQ
Orthopediatrics Corp. has filed a definitive proxy statement with the SEC, indicating upcoming shareholder actions.
NASDAQ
OrthoPediatrics Corp. will hold its 2025 annual meeting of stockholders on May 23, 2025, to elect directors, approve executive compensation, and ratify the appointment of Deloitte & Touche LLP as its independent auditor.
NASDAQ
Orthopediatrics Corp. has filed a definitive proxy statement with the SEC, indicating upcoming shareholder actions.
NASDAQ
OrthoPediatrics Corp. will hold its 2024 annual meeting of stockholders on May 24, 2024, to elect directors, approve executive compensation, adopt an incentive award plan, and ratify the appointment of its independent auditor.